Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. Dec. 27, 2017. Michael Mussallem.

Executive Summary

Check out what Edwards Lifesciences CEO Michael Mussallem has to say about why it's important for his company to address the needs of patients who rely on transcatheter aortic valve replacement (TAVR) systems.

"We are aggressively pursuing a whole toolbox of therapies for mitral and tricuspid therapies. This is a group of patients that's underserved. They just don't have great answers today. And even though it's not clear that we have all the answers, we're optimistic about it, that some of this is underpinned by our success in TAVR, some of it is just because of the enthusiasm we feel from the clinical community, but we're as optimistic as ever about the opportunity here and we're excited about the challenges ahead and what we might be able to do to tackle those." – Michael Mussallem, CEO, Edwards Lifesciences

> Find out more: Edwards Adds To Wide Range Of Approaches To Mitral Repair

Click here for a free trial of Medtech Insight


Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

MT121950

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel